The hMLH1 promoter polymorphisms and cancer susceptibility in Asian populations: A meta-analysis

Gene

Volumn 523, Issue 2, 2013, Pages 199-204

  He, Yuanzhou ^a   Xu, Xiangqin ^a   Chen, Huilong ^a   Wang, Jianmiao ^a   Xiong, Weining ^a   Xu, Yongjian ^a   Liu, Jin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Asian populations; Cancer; HMLH1; Meta analysis; Polymorphisms

Indexed keywords

PROTEIN MLH1; MLH1 PROTEIN, HUMAN; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ARTICLE; ASIAN; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HETEROZYGOTE; HUMAN; LUNG CANCER; META ANALYSIS (TOPIC); PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; STOMACH CANCER; ALLELE; ASIA; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; META ANALYSIS; NEOPLASM; RISK;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALLELES; ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; NEOPLASMS; NUCLEAR PROTEINS; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK;

MLCS; MLOWN;

EID: 84880422531     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.03.138     Document Type: Article

References (46)

1. An Y., Jin G., Wang H., et al. Polymorphisms in hMLH1 and risk of early-onset lung cancer in a southeast Chinese population [J]. Lung Cancer 2008, 59(2):164-170.
2. Arnold C.N., Goel A., Blum H.E., Boland C.R. Molecular pathogenesis of colorectal cancer: implications for molecular diagnosis. Cancer 2005, 104:2035-2047.
3. Bellacosa A. Functional interactions and signaling properties of mammalian DNA mismatch repair proteins. Cell Death Differ. 2001, 8:1076-1092.
4. Cannavo E., Gerrits B., Marra G., Schlapbach R., Jiricny J. Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. J. Biol. Chem. 2007, 282:2976-2986.
5. Cejka P., Stojic L., Mojas N., Russell A.M., Heinimann K., Cannavo E., di Pietro M., Marra G., Jiricny J. Methylation induced G(2)/M arrest requires a full complement of the mismatch repair protein hMLH1. EMBO J. 2003, 22:2245-2254.
6. Cheung W.Y., Liu G. Genetic variations in esophageal cancer risk and prognosis. Gastroenterol. Clin. North Am. 2009, 38(1):75-91.
7. Deng D.J., Zhou J., Zhu B.D., Ji J.F., Harper J.C., Powell S.M. Silencing-specific methylation and single nucleotide polymorphism of hMLH1 promoter in gastric carcinomas. World J. Gastroenterol. 2003, 9:26-29.8.
8. Deng D.J., Zhou J., Zhu B.D., et al. Silencing-specific methylation and single nucleotide polymorphism of hMLH1 promoter in gastric carcinomas [J]. World J. Gastroenterol. 2003, 9(1):26-29.
9. Fleisher A.S., Esteller M., Wang S., Tamura G., Suzuki H., Yin J., Zou T.T., Abraham J.M., Kong D., Smolinski K.N., Shi Y.Q., Rhyu M.G., Powell S.M., James S.P., Wilson K.T., Herman J.G., Meltzer S.J. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res. 1999, 59:1090-1095.
10. Hall M.C., Shcherbakova P.V., Fortune J.M., Borchers C.H., Dial J.M., Tomer K.B., Kunkel T.A. DNA binding by yeast Mlh1 and Pms1: implications for DNA mismatch repair. Nucleic Acids Res. 2003, 31:2025-2034.
11. Herman J.G., Umar A., Polyak K., Graff J.R., Ahuja N., Issa J.P., Markowitz S., Willson J.K., Hamilton S.R., Kinzler K.W., Kane M.F., Kolodner R.D., Vogelstein B., Kunkel T.A., Baylin S.B. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998, 95:6870-6875.
12. Herman J.G., Umar A., Polyak K., et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl Acad. Sci. USA 1998, 95:6870-6875.
13. Hibi K., Takahashi T., Yamakawa K., Ueda R., Sekido Y., Ariyoshi Y., et al. Three distinct regions involved in 3p deletion in human lung cancer. Oncogene 1992, 7:445-449.
14. Hsu H.S., Wen C.K., Tang Y.A., Lin R.K., Li W.Y., Hsu W.H., et al. Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer. Clin. Cancer Res. 2005, 11:5410-5416.
15. Ito E., Yanagisawa Y., Iwahashi Y., et al. A core promoter and a frequent single-nucleotide polymorphism of the mismatch repair gene hMLH1 [J]. Biochem. Biophys. Res. Commun. 1999, 256(3):488-494.
16. Jin G.R., Lin C.Z., et al. The association between hMLH1 polymorphism and risk of breast cancer [J]. Guangdong Medical Journal 2011, 32(10):1280-1281.
17. Kane M.F., Loda M., Gaida G.M., Lipman J., Mishra R., Goldman H., Jessup J.M., Kolodner R. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 1997, 57:808-811.
18. Kang G.H., Shim Y.H., Ro J.Y. Correlation of methylation of the hMLH1 promoter with lack of expression of hMLH1 in sporadic gastric carcinomas with replication error. Lab. Invest. 1999, 79:903-909.
19. Kim J.C., Roh S.A., Koo K.H., Ka I.H., Kim H.C., Yu C.S., et al. Genotyping possible polymorphic variants of human mismatch repair genes in healthy Korean individuals and sporadic colorectal cancer patients. Fam. Cancer 2004, 3:129-137.
20. Kim J.C., Roh S.A., Koo K.H., Ka I.H., Kim H.C., Yu C.S., Lee K.H., Kim J.S., Lee H.I., Bodmer W.F. Genotyping possible polymorphic variants of human mismatch repair genes in healthy Korean individuals and sporadic colorectal cancer patients. Fam. Cancer 2004, 3:129-137.
21. Li G.M. DNA mismatch repair and cancer. Front. Biosci. 2003, 8:d997-d1017.
22. Li G.M. Mechanisms and functions of DNA mismatch repair. Cell Res. 2008, 18:85-98.
23. Li H.C., Feng H.Y., Zhang X.P., et al. Association of mismatch repair gene polymorphism with susceptibility to sporadic colorectal cancer in Tianjin region [J]. Yi Chuan 2010, 32(12):1241-1246.
24. Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., Hirschhorn J.N. Metaanalysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet. 2003, 33:177-182.
25. Lynch H.T., Lynch P.M., Lanspa S.J., Snyder C.L., Lynch J.F., Boland C.R. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin. Genet. 2009, 76:1-18.
26. Manuguerra M., Saletta F., Karagas M.R., Berwick M., Veglia F., et al. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am. J. Epidemiol. 2006, 164:297-302.
27. McDaid J.R., Loughery J., Dunne P., Boyer J.C., Downes C.S., Farber R.A., Walsh C.P. MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea. Br. J. Cancer 2009, 101:441-451.
28. Moslein G., Tester D.J., Lindor N.M., Honchel R., Cunningham J.M., French A.J., Halling K.C., Schwab M., Goretzki P., Thibodeau S.N. Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum. Mol. Genet. 1996, 5:1245-1252.
29. Okada T., Noji S., Goto Y., Iwata T., Fujita T., Okada T., et al. Immune responses to DNA mismatch repair enzymes hMSH2 and hPMS1 in patients with pancreatic cancer, dermatomyositis and polymyositis. Int. J. Cancer 2005, 116:925-933.
30. Park S.H., Lee G.Y., Jeon H.S., et al. 93G->A polymorphism of hMLH1 and risk of primary lung cancer [J]. Int. J. Cancer 2004, 112(4):678-682.
31. Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J. Clin. Oncol. 2003, 21:1174-1179.
32. Pharaoh P.D., Dunning A.M., Ponder B.A., Easton D.F. Association studies for finding cancer-susceptibility genetic variants. Nat. Rev. Cancer 2004, 4:850-860.
33. Shi X., Xu G., Zhao C., Ma J., Zhang Y., Lv S., Yang Q. A single-strand conformation polymorphism method by capillary electrophoresis with laser-induced fluorescence for detection of the T1151A mutation in hMLH1 gene. Electrophoresis 2003, 24:2316-2321.
34. Shi W.P., Bian J.C., Jiang F., et al. Association of genetic polymorphisms and haplotypes in hMLH1 and hMSH3 gene with the risk of papillary thyroid carcinoma [J]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2008, 25(4):390-395.
35. Shih C.M., Chen C.Y., Lee I.H., et al. A polymorphism in the hMLH1 gene (-93G->A) associated with lung cancer susceptibility and prognosis [J]. Int. J. Mol. Med. 2010, 25(1):165-170.
36. Shin K.H., Shin J.H., Kim J.H., et al. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene [J]. Cancer Res. 2002, 62(1):38-42.
37. Shin Y.K., Heo S.C., Shin J.H., Hong S.H., Ku J.L., Yoo B.C., et al. Germline mutations in MLH1 MSH2 and MSH6 in Korean hereditary non-polyposis colorectal cancer families. Hum. Mutat. 2004, 24:351.
38. Stojic L., Brun R., Jiricny J. Mismatch repair and DNA damage signalling. DNA Repair (Amst.) 2004, 3:1091-1101.
39. Tanaka Y., Zaman M.S., Majid S., Liu J., Kawakami K., Shiina H., Tokizane T., Dahiya A.V., Sen S., Nakajima K. Polymorphisms of MLH1 in benign prostatic hyperplasia and sporadic prostate cancer. Biochem. Biophys. Res. Commun. 2009, 383:440-444.
40. Thibodeau S.N., Bren G., Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993, 260:816-819.
41. Wright M.E., Peters U., Gunter M.J., Moore S.C., Lawson K.A., Yeager M., Weinstein S.J., Snyder K., Virtamo J., Albanes D. Association of variants in two vitamin e transport genes with circulating vitamin concentrations and prostate cancer risk. Cancer Res. 2009, 69(4):1429-1438.
42. Wu J., Wang D., Song L., et al. A new familial gastric cancer-related gene polymorphism: T1151A in the mismatch repair gene hMLH1 [J]. Mol. Biol. Rep. 2011, 38(5):3181-3187.
43. Xiao X.Q., Wang S.S., Tian Y.Y., et al. The association between hMLH1 -93G>A promoter polymorphism and risk of gastric cancer [J]. Acta University Medicinalis NANJING(Natural Science) 2010, (8):1151-1155.
44. Xinarianos G., Liloglou T., Prime W., Maloney P., Callaghan J., Fielding P., et al. hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas. Cancer Res. 2000, 60:4216-4221.
45. Zhang X.M., Li J.T., Zhu M., et al. Study on the relationship between genetic polymorphism Val384Asp in hMLH1 gene and the risk of four different carcinomas [J]. Zhonghua Liu Xing Bing Xue Za Zhi 2004, 25(11):978-981.
46. Zhang L.L., CAO J., Shen W.D., et al. Correlation between hMLH1 -93G/A gene polymorphism and colorectal cancer [J]. Gastroenterol 2011, 16(4):214-217.